Overview

A Phase2 of A-101 Topical Solution in Subjects With Common Warts

Status:
Completed
Trial end date:
2018-03-16
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to evaluate the effectiveness of A-101 compared to vehicle when applied to 1 common target wart on the trunk or extremities.
Phase:
Phase 2
Details
Lead Sponsor:
Aclaris Therapeutics, Inc.
Treatments:
Pharmaceutical Solutions